Survival impact of the number of lymph node retrieved on patients with node-negative gastric cancer: more is better? Hsu JT*, Le PH, Kuo CJ, Yeh TS, Jan YY. Transl Gastroenterol Hepatol 2017
Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1. J Surg Res 2017 May Hsu JT, Hsu CS, Le PH, Chen TC, Chou WC, Lin CY*, Yeh TS*.
Mechanism of salutary effects of melatonin-mediated liver protection after trauma-hemorrhage: p38 MAPK-dependent iNOS/HIF-1α pathway. Am J Physiol Gastrointest Liver Physiol 2017 May Hsu JT*, Le PH, Lin CJ, Chen TH, Kuo CJ, Chiang KC, Yeh TS.
Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study. Oncotarget 2017 Apr Hsu JT*, Le PH, Kuo CF, Chiou MJ, Kuo CJ, Chen TH, Lin CJ, Chen JS, Yu HP, Chiang KC, Yeh CN*, Jan YY, Yeh TS.
Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer. BMC Palliat Care 2017 Mar Hsu JT*, Liao JA, Chuang HC, Chen TD, Chen TH, Kuo CJ, Lin CJ, Chou WC, Yeh TS, Jan YY.
Vascular endothelial growth factor expression is an independent poor prognostic factor for HER-2 positive gastric cancer. J Surg Res 2017 Feb Hsu JT*, Chen TD, Chuang HC, Huang SC, Le PH, Chen TH, Lin CJ, Yeh TS.